期刊文献+

子宫内膜癌癌周内膜病理学特征与临床分析 被引量:1

The Relationship between the Pathologic Features of the Uninvolved Endometrium and Prognosis in Postmenopausal Carcinoma
下载PDF
导出
摘要 目的研究绝经后子宫内膜癌癌周内膜的病理学特征与临床及预后的关系。方法根据癌周内膜的组织学表现分为增生型和萎缩型两组,对23例子宫内膜癌患者的临床与病理特点和5年随访结果进行回顾性分析。结果癌周内膜呈增生型的子宫内膜癌患者伴发高血压、肥胖、糖耐量异常、子宫内膜增生过长史的机率显著高于癌周内膜呈萎缩型的子宫内膜癌患者(P<0.01);癌周内膜呈萎缩型者较增生型者呈低分化倾向及深肌层浸润(P<0.01);5年生存率,癌周内膜呈增生型子宫内膜癌患者为87.5%,萎缩型为40.0%(P<0.05)。结论子宫内膜癌癌周内膜不同的病理学特征与预后相关,癌周内膜呈增生型者的预后好于萎缩型。 Objective To investigate the relationship between the pathologic features of the uninvolved endometrium and prognosisin postmenopausal endometrial carcinoma. Methods The clinicopathologic features of 23 cases ot endometrial carcinoma were analyzed retrospectively. Results According to the proliferative uninvolved endometeium(PUE) were more much related with the clinical risk factors than those of atrophic uninvolved endometrium(AUE)(P〈 0.01). Aue cases had much worse grade,much deeper myometrial invasion(P〈0.01). The overall 5 year survival rate lwas 87.5%in the PUE and 40.0% in the AUE cases(P〈0.05). Conclusion The histopathologic types of the uninvolved endometrium were related to the prognosis of the patients with endometrial carcinoma. The patients with proliferative uninvolved endometrium had better prognosis than those with atrophic uninvolved endometrium.
出处 《中国现代医生》 2009年第18期191-192,共2页 China Modern Doctor
关键词 子宫内膜癌 癌周内膜 病理分型 预后 Endometrial neoplasms Uninvolved Endometrium Histopathology Prognosis
  • 相关文献

参考文献6

  • 1Mikuta JJ. International federation of gynecology and obstetrice staging of endometrial cancer 1988[J]. Cancer, 1993,71 : 1460.
  • 2Deligdisch L,Cohen CJ. Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia[J]. Cancer, 1985,56:1452.
  • 3曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2005:2814.
  • 4Karen H, Larrissa N, Liane D. Endometrial carcinoma in eld women[J]. Gynecol Oncol, 1995,58:198.
  • 5伊铁忠,糜若然,朱莉.子宫内膜癌PTENPCNA和C-erbB-2的表达及其意义[J].中国实用妇科与产科杂志,2006,22(2):127-128. 被引量:19
  • 6汤淼云,欧阳新宇.子宫内膜癌淋巴结转移规律及相关因素分析[J].中国实用妇科与产科杂志,2008,24(8):622-623. 被引量:10

二级参考文献7

共引文献381

同被引文献16

  • 1Honda S,Shirotani-Ikejima H,Tadokoro S,et al.Integrin-linked kinase associated with integrin activation[J].Blood,2009,113(21):5304-5313.
  • 2McPhee TR,McDonald PC,Oloumi A,et al.Integrin-linked kinase regulates E-cadherin expression through PARP-I[J].Dev Dyn,2008,237 (10):2737-2747.
  • 3Assi K,Mills J,Owen D,et al.Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis -associated carcinogenesis[J].Gut,2008,57(7):931-940.
  • 4Watzka SB,Setinek U,Huber M,et al.Reactivity of integrin-linked kinase in human mesothelial cell proliferation[J]. Interact Cardiovasc Thorac Surg, 2008,7(1):107-110.
  • 5Peroukides S,Bravou V,Varakis J,et al.ILK overexpression in human hepatocellular carcinoma and liver cirrhosis correlates with activation of Akt[J].Oncol Rep,2008,20(6): 1337-1344.
  • 6Goulioumis AK,Bravou V,Varakis J,et al.Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas [J].Virchows Arch,2008, 453(5):511-519.
  • 7McDonald PC,Fielding AB,Dedhar S.Integrin-linked kinase-essential roles in physiology and cancer biology[J].J Cell Sci,2008,121 (19):3121- 3132.
  • 8Kalogiannidis I,Bobos M,Papanikolaou A,et al.Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes[J].Eur J Gynaecol Oncol,2008,29(1):19- 25.
  • 9Ishikawa A,Kudo M,Nakazawa N,et al.Expression of keratinocyte growth factor and its receptor in human endometrial cancer in cooperation with steroid hormones[J].Int J Oncol,2008,32(3):565-574.
  • 10于翠珍,李双标,孙德飞.整合素连接激酶在卵巢肿瘤组织中的表达及意义[J].中国实用妇科与产科杂志,2007,23(9):712-713. 被引量:8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部